The pejorative prognostic value of Sox2 was confirmed by multivariate survival analysis (HR = 1.48, 95% CI 1.02–2.15, p = 0.0420), with tumor size, ER and AR as the covariates (p < 0.0001, Cox proportional-hazard regression, Table 3). This evidence concerns the gene SOX2 and neoplasm.